did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780470118801

Quantitative Imaging Tools for Lung Cancer Drug Assessment

by ;
  • ISBN13:

    9780470118801

  • ISBN10:

    0470118806

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2008-04-14
  • Publisher: Wiley-OSA

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $191.94 Save up to $57.58
  • Rent Book $134.36
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 3-4 BUSINESS DAYS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

Cancer Research and Prevention Monographpresents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise. This book has contributions from recognized experts in CAD, medical information technology systems, regulatory procedure, x-ray standards development, and clinical trial design. These expert contributors discuss the current state of the art and provide a road map for directing further research in lung cancer and other diseases.

Author Biography

James L. Mulshine, MD, is a Professor of Internal Medicine, Associate Provost of Research and Vice President, Rush University Medical Center in Chicago, Illinois.?In this position, Dr. Mulshine is the primary academic officer responsible for managing research activities at Rush University Medical School. He is an internationally recognized expert on lung cancer.?Over the last few years, Dr. Mulshine has been working with a range of organizations to accelerate the use of high resolution spiral CT in the quantitative evaluation of drug response for early lung cancer.

Table of Contents

Contributorsp. vii
Prefacep. ix
Incorporating Imaging into Drug Development: An Industry Perspectivep. 1
Advances in Lung Cancer Treatmentp. 17
Quantitative Imaging in CT Lung Cancer Drug Development and Evaluationp. 39
Volumetric CT Imaging for Response Assessment in Lung Cancer: A Platform for Translational Researchp. 53
Emerging Radiological Software Standards and Development Technologies: Impact on Clinical Translation and Trialsp. 67
Statistical Considerations Underlying Therapeutic Response Criteria for Lung Cancer: Multislice CT Scanners and CAD Algorithms for Volumetric Assessmentp. 95
Programs Supporting Quantitative Imaging in Biomedicine at the National Institute of Standards and Technologyp. 111
Evolving Imaging Resources: Public Access Databasesp. 123
Biomedical Imaging Archive Networkp. 131
Developing CT Image-Processing Tools to Accelerate Progress in Lung Cancer Drug Developmentp. 141
Indexp. 155
Table of Contents provided by Ingram. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program